New Drug Applications Archive
Get news by email or subscribe to our news feeds.
News Archive for July 2012
July 2, 2012
July 3, 2012
- Chelsea Therapeutics Provides an Update on Northera (droxidopa) Regulatory Status and Development Program
- ThromboGenics Announces FDA Accepts Filing and Grants Priority Review to Its Biologics License Application for Ocriplasmin Intravitreal Injection
July 6, 2012
July 10, 2012
July 16, 2012
July 26, 2012
July 27, 2012
- FDA Advisory Committee Recommends ThromboGenics' Ocriplasmin for the Treatment of Symptomatic Vitreomacular Adhesion (VMA)
- Takeda Resubmits New Drug Applications to the United States Food and Drug Administration for Alogliptin and the Fixed-Dose Combination Alogliptin and Pioglitazone
